Plasma procalcitonin concentrations predict organ dysfunction and outcome in dogs with sepsis
Authors:
Open Access
- 27 March 2018
- journal article
- research article
- Published by Springer Nature in BMC Veterinary Research
- Vol. 14 (1) , 1-9
Abstract
Procalcitonin (PCT) is a valuable prognostic biomarker in human sepsis that is predictive of organ dysfunction, septic shock and mortality. Data on PCT in dogs is limited. This study aimed to investigate the prognostic value of baseline and serial PCT measurements in dogs with sepsis and to determine the association between PCT and sepsis severity and the presence of organ dysfunction. PCT concentrations were measured in citrated plasma samples collected from 53 dogs with sepsis at the time of admission (T0, n = 53) and at 24 h (T1, n = 35) and 48 h (T2, n = 30) post-admission using a commercial ELISA. Dogs were classified by sepsis severity (sepsis without organ dysfunction; severe sepsis; septic shock) and outcome (survivors; non-survivors). Organ dysfunctions were recorded at T0 and during hospitalization, and the APPLEfast score calculated at T0. Healthy dogs (n = 12) were used as controls. There were 18 septic dogs without organ dysfunction, 24 dogs with severe sepsis and 11 with septic shock. Baseline PCT concentrations were significantly greater in dogs with sepsis compared to healthy controls (P < 0.0001), and in dogs with septic shock compared to dogs without cardiovascular compromise (P = 0.01). Baseline PCT was significantly correlated with organ dysfunction (P = 0.003). Declining PCT concentrations were documented in survivors at T1 and T2 compared to PCT at T0 (P = 0.0006), and PCT clearance at 24 h was significantly higher in survivors (n = 38) compared to non-survivors (n = 15) (P = 0.037). Canine APPLEfast score was not predictive of sepsis severity, the development of MODS or outcome. In dogs with sepsis, PCT concentrations at hospital admissions are predictive of organ dysfunction and septic shock. Serial procalcitonin monitoring may offer valuable prognostic information in canine sepsis, wherein early decreases in PCT concentrations are associated with survival.Keywords
Funding Information
- College of Veterinary Medicine, Cornell University
- Università di Bologna (BIR15Q8)
This publication has 56 references indexed in Scilit:
- Positive impact of an emergency department protocol on time to antimicrobial administration in dogs with septic peritonitisJournal of Veterinary Emergency and Critical Care, 2013
- Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock. A prospective pilot studyMedicina Intensiva (English Edition), 2012
- Procalcitonin to Guide Initiation and Duration of Antibiotic Treatment in Acute Respiratory Infections: An Individual Patient Data Meta-AnalysisClinical Infectious Diseases, 2012
- Sepsis biomarkers: a reviewCritical Care, 2010
- Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trialThe Lancet, 2010
- Long-term stability of procalcitonin in frozen samples and comparison of Kryptor® and VIDAS® automated immunoassaysClinical Biochemistry, 2010
- Association between outcome and organ system dysfunction in dogs with sepsis: 114 cases (2003–2007)Journal of the American Veterinary Medical Association, 2010
- Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trialCritical Care, 2009
- Cardiac troponin I levels in canine pyometraActa Veterinaria Scandinavica, 2007
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006